AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
Elekta has 11.8 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: Elekta (elekta.com)
Elekta is a rare example of a company that uses heavy emotional marketing as a wrapper for high-density forensic evidence. While the ‘About Us’ content is standard corporate fluff, the product-specific content is scientifically rigorous, making the overall BS levels remarkably low for a global healthcare entity.
Implement Organization and MedicalWebPage schema to bridge the technical credibility gap. Replace generic headers in the ‘About Us’ section with specific corporate milestones (e.g., ’50 years of innovation’ should be ‘Since 1972: From Gamma Knife to Elekta Unity’). Add sameAs links to the cited researchers (Dr. Lampe/Prof. Price) to verify their external authority. Convert the ‘Making a difference together’ section into a formal Case Study library with structured outcomes.
While the Homepage and Careers pages utilize high-saturation power words like ‘unlimited opportunities’ and ‘build hope,’ the technical sub-pages demonstrate extreme substance. The Adaptive Radiotherapy page provides granular data, citing that ‘90% of adapted fractions need plan changes’ and identifying a ‘5x reduction in GU toxicity.’ This forensic detail offsets the generic ‘Where every difference counts’ marketing fluff found in the About Us section.
Blocked resources, unstable DOMs, and redirect heavy paths create blind spots in your semantic graph. Run a full Crawlability & Indexation analysis to map every point where AI loses access to your content.
The transition from the Homepage H1 ‘Nobody does adaptive like Elekta’ to the sub-pages is highly coherent. Unlike sites that drift into generic services, the sub-page ‘Adaptive Radiotherapy’ specifically delivers on the H1 promise by defining Online vs. Offline adaptive therapy and providing evidence-based justifications. There is a slight disconnect in the ‘About Us’ page, which shifts from the technical authority of the product into purely emotional ‘humanity’ tropes without providing operational milestones.
Stop the ROI leak caused by technical debt and strategic misalignment. Conduct an Independent Strategic Diagnosis for 1 Euro to identify high impact issues across all audit categories.
The site largely avoids trust theatre by providing legitimate ‘proof paths’ to external sources. Rather than just claiming success, the Adaptive Radiotherapy page includes a ‘References’ section with links to ClinicalTrials.gov, Lancet Oncology (2023), and PubMed (MIRAGE Trial). However, the trust_theatre_flag is true on the Careers page due to a single unverified review and lack of external validation for ‘Life at Elekta’ claims.
Proof density is exceptionally high for the industry, with a verifiable evidence ratio that favors substantiation. The site moves beyond vague assertions of ‘better outcomes’ to cite the ‘HERMES trial’ and ‘Chuong et al., 2023.’ The presence of five distinct clinical trial links at the footer of the product page creates a robust evidentiary foundation.
To evaluate URL identity stability and multilingual coherence, review the Yoast Identity Stability audit. View the Yoast Identity Stability Audit for a practical example of canonical alignment and language layer integrity.
The Careers and About Us pages suffer from a high commodity fingerprint, using industry cliches like ‘innovation and collaboration thrive’ and ‘passionate about what we do’ that could belong to any global corporation. Conversely, the technical value proposition regarding ‘Adaptive’ treatment is highly differentiated and would be difficult for a generic competitor to copy-paste without the specific trial data Elekta provides.
There is a notable authority gap in the structured data; all pages returned schema_json as null. While the text cites experts like ‘Dr. Lampe’ and ‘Prof. Pat Price,’ they lack digital footprints via Person schema or sameAs links to academic profiles. This prevents the technical implementation from reaching the high-authority status suggested by the clinical citations.
The marketing tone is aggressive, but the disconnect is minimal because the claims are substantiated by specific metrics. For example, the claim that ‘Margins matter’ is immediately followed by a reference to the UNITED trial showing safe margin reduction in high-grade gliomas. This is a rare instance where the marketing ‘Signal’ is closely mirrored by technical ‘Substance.’
Medical Devices, Pharma & Biotech BS: Elekta (elekta.com)
The website perfectly aligns with the Medical Devices and Pharma & Biotech category. It utilizes specialized terminology such as ‘hypofractionated schedules,’ ‘SBRT,’ and ‘GU toxicity,’ while referencing clinical trials like MIRAGE and UNITED, confirming its role as a high-complexity healthcare technology provider.
A page with no inbound links is invisible to AI, no matter how strong the content is. Open the Internal Linking Framework Guide to learn how link driven relationships shape retrieval, authority, and entity grouping.
“The score of 29 is primarily driven by the 'Identity and Authority' and 'Commodity Fingerprint' pillars. While the technical content is high-substance, the lack of structured data (Schema) and the boilerplate nature of the HR and Corporate sections prevent a 'Minimal BS' score. The 'Adaptive Radiotherapy' page is the strongest anchor, preventing the score from entering the 'Moderate' or 'High' BS ranges.”